FGFR1 in metastatic and primary lobular breast carcinoma. A biological rationale for new therapeutic option

被引:0
|
作者
Brunello, E. [1 ]
Brunelli, M. [1 ]
Nottegar, A. [1 ]
Manfrin, E. [1 ]
Pedron, S. [1 ]
Vittoria, E. [1 ]
Chilosi, M. [1 ]
Gobbo, S. [1 ]
Martignoni, G. [1 ]
Bonetti, F. [1 ]
机构
[1] Univ Verona, I-37100 Verona, Italy
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:S3 / S3
页数:1
相关论文
共 50 条
  • [1] FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
    Reis-Filho, Jorge Sergio
    Simpson, Pete T.
    Turner, Nicholas C.
    Lambros, Maryou Ballo
    Jones, Chris
    Mackay, Alan
    Grigoriadis, Anita
    Sarrio, David
    Savage, Kay
    Dexter, Tim
    Iravani, Marjan
    Fenwick, Kerry
    Weber, Barbara
    Hardisson, David
    Schmitt, Fernando Carlos
    Palacios, Jose
    Lakhani, Sunil R.
    Ashworth, Alan
    CLINICAL CANCER RESEARCH, 2006, 12 (22) : 6652 - 6662
  • [2] Rationale for treatment of metastatic squamous cell carcinoma of the lung using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Schroeck, A.
    Scheble, V.
    Kirsten, R.
    Menon, R.
    Goltz, D.
    Boehm, D.
    Vogel, W.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S51 - S51
  • [3] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    MODERN PATHOLOGY, 2012, 25 : 477A - 477A
  • [4] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Menon, R.
    Goltz, D.
    Scheble, V.
    Kirsten, R.
    Vogel, W.
    Boehm, D.
    Schroeck, A.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S195 - S195
  • [5] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    LABORATORY INVESTIGATION, 2012, 92 : 477A - 477A
  • [6] Primary and metastatic lobular carcinoma of the breast
    Harake, MDJ
    Maxwell, AJ
    Sukumar, SA
    CLINICAL RADIOLOGY, 2001, 56 (08) : 621 - 630
  • [7] FGFR1 as a prognostic biomarker and potential therapeutic target in head and neck squamous cell carcinoma.
    Willems, Stefan M.
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline Md
    Noorlag, Rob
    Bijlsma, Rhode
    van Es, RobertJ. J.
    Lieftink, Cor
    de Bree, Remco
    Bernards, Rene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Comprehensive molecular genetic analysis reveals FGFR1 as a potential therapeutic target for lobular breast carcinomas
    Reis Filho, J. S.
    Simpson, P. T.
    Turner, N.
    Lambros, M. B. K.
    Jones, C.
    Mackay, A.
    Grigoriadis, A.
    Sarrio, D.
    Savage, K.
    Dexter, T.
    Iravani, M.
    Fenwick, K.
    Weber, B.
    Hardisson, D.
    Schmitt, F. C.
    Palacios, J.
    Lakhani, S. R.
    Ashworth, A.
    JOURNAL OF PATHOLOGY, 2006, 210 : 59 - 59
  • [9] FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
    Brunello, Eleonora
    Brunelli, Matteo
    Bogina, Giuseppe
    Calio, Anna
    Manfrin, Erminia
    Nottegar, Alessia
    Vergine, Marco
    Molino, Annamaria
    Bria, Emilio
    Massari, Francesco
    Tortora, Giampaolo
    Cingarlini, Sara
    Pedron, Serena
    Chilosi, Marco
    Zamboni, Giuseppe
    Miller, Keith
    Martignoni, Guido
    Bonetti, Franco
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [10] FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
    Eleonora Brunello
    Matteo Brunelli
    Giuseppe Bogina
    Anna Caliò
    Erminia Manfrin
    Alessia Nottegar
    Marco Vergine
    Annamaria Molino
    Emilio Bria
    Francesco Massari
    Giampaolo Tortora
    Sara Cingarlini
    Serena Pedron
    Marco Chilosi
    Giuseppe Zamboni
    Keith Miller
    Guido Martignoni
    Franco Bonetti
    Journal of Experimental & Clinical Cancer Research, 31